Implementing Evidence-Based Treatment for Common Mental Disorders in HIV Clinics in Ukraine

在乌克兰艾滋病毒诊所对常见精神疾病实施循证治疗

基本信息

  • 批准号:
    10762576
  • 负责人:
  • 金额:
    $ 19.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2028-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY From 2010-2020, Eastern Europe reported a 72% increase in new adult HIV infections, representing the highest rate of increase globally. Among the Eastern European countries, the HIV epidemic in Ukraine is one of the largest, with nearly 260,000 people with HIV (PWH). Nevertheless, in 2020, only 54% of Ukrainian PWH were on antiretroviral therapy (ART), and only 51% were virally suppressed. These suboptimal HIV care continuum outcomes are partially attributable to mental disorders, which are more prevalent among PWH generally (and in Ukraine specifically) and have been linked to decreased ART adherence and poor engagement in HIV care. To minimize the adverse effects of impaired mental health on HIV outcomes, creating a pathway to increase access to evidence-based mental health care is a critical public health need. The long- term goal of this applicant is to develop expertise in testing transdiagnostic mental health interventions to improve HIV outcomes among PWH in Ukraine. The objective of this K23 application is to adapt the Common Elements Treatment Approach (CETA), by incorporating the single-session Life Steps ART adherence intervention, to reduce symptoms of depression, anxiety, and posttraumatic stress among PWH in Ukraine. The central hypothesis to be tested is that the adapted CETA plus Life-Steps intervention will improve both HIV and mental health outcomes among PWH in Ukraine. The strong preliminary data supporting this application shows that community psychologists in Ukraine feel they do not have adequate knowledge to deliver mental health treatment but nonetheless have strong interest in learning short-term treatments such as CETA. To test the central hypothesis, the following specific aims are proposed: (1) To define relevant clinical and contextual factors for adapting CETA for delivery in HIV clinics and for integrating Life-Steps into the existing protocol; (2) To determine the feasibility, acceptability, and preliminary efficacy of the adapted CETA plus Life-Steps intervention; and (3) To estimate potential mediators and moderators of the adapted CETA plus Life-Steps intervention. The expected outcome of this K23 is that this applicant will gain the expertise needed in the three critical training areas of HIV and mental health, design of randomized clinical trials, and longitudinal data analysis necessary to achieve research independence. The key innovation is that this study will be the first to combine CETA with Life-Steps and evaluate its preliminary efficacy in a low- or middle-income country setting. The resulting preliminary data will also support a compelling R01 application, to be submitted in year 4 of the K23 award period, to test the adapted CETA plus Life-Steps intervention in a fully-powered, multi-site efficacy study in Ukraine. If successful, the proposed research will have significant public health impact by providing an evidence-based intervention for treating mental health problems among PWH, with attendant implications for addressing the dual mental health crisis and HIV epidemic in PWH populations throughout Eastern Europe.
项目摘要 从2010年到2020年,东欧报告的新成人艾滋病毒感染增加了72%, 全球增长率最高。在东欧国家中,乌克兰的艾滋病毒疫情是一个 其中最大的一个,有近260,000名艾滋病毒感染者(PWH)。然而,到2020年,只有54%的乌克兰PWH 接受抗逆转录病毒治疗(ART)的患者中,只有51%的人受到病毒抑制。这些不理想的艾滋病护理 持续性结果部分归因于精神障碍,精神障碍在威尔斯亲王医院中更为普遍 一般来说(特别是在乌克兰),并已与减少抗逆转录病毒疗法坚持和穷人 参与艾滋病护理。为了尽量减少心理健康受损对艾滋病毒结果的不利影响, 增加获得循证精神卫生保健的途径是一项关键的公共卫生需求。很长的- 本申请人的长期目标是发展测试跨诊断心理健康干预的专业知识, 改善乌克兰公共卫生服务提供者的艾滋病毒防治成果。此K23应用程序的目标是调整通用 元素治疗方法(CETA),通过纳入单次会议的生活步骤ART坚持 在乌克兰,我们正在进行干预,以减少PWH中的抑郁、焦虑和创伤后压力症状。 有待检验的中心假设是,经过调整的CETA加生活步骤干预将改善艾滋病毒感染和艾滋病感染。 和精神健康结果之间的PWH在乌克兰。支持这一申请的有力的初步数据 显示,乌克兰的社区心理学家认为他们没有足够的知识来提供心理咨询, 健康治疗,但仍然有强烈的兴趣学习短期治疗,如CETA。测试 中心假设,提出以下具体目标:(1)定义相关的临床和背景 调整CETA在艾滋病诊所分娩和将生命步骤纳入现有方案的因素;(2) 确定调整后的CETA加生活步骤的可行性、可接受性和初步疗效 评估适应性CETA加生活步骤的潜在中介和调节因素 干预K23的预期结果是,申请人将获得三个领域所需的专业知识。 艾滋病毒和心理健康的关键培训领域,随机临床试验的设计,以及纵向数据 分析,以实现研究的独立。关键的创新是,这项研究将是第一个 联合收割机结合CETA与生活步骤,并评估其在低收入或中等收入国家环境中的初步疗效。 由此产生的初步数据也将支持一个令人信服的R 01申请,将在2010年的第4年提交。 K23奖励期,以测试调整后的CETA加Life-Steps干预在全功率、多部位的有效性 研究在乌克兰.如果成功,拟议的研究将通过提供一个 循证干预治疗威尔斯亲王医院精神健康问题, 解决东欧地区威尔斯亲王医院患者的双重精神健康危机和艾滋病毒流行问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kimberly Michelle Hook其他文献

Kimberly Michelle Hook的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kimberly Michelle Hook', 18)}}的其他基金

Preventing Mental Disorders Among Women Internally Displaced by War in Ukraine: The SHAWL Trial
预防乌克兰境内因战争而流离失所的妇女的精神障碍:SHAWL 审判
  • 批准号:
    10730622
  • 财政年份:
    2023
  • 资助金额:
    $ 19.06万
  • 项目类别:

相似海外基金

Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
  • 批准号:
    10568717
  • 财政年份:
    2023
  • 资助金额:
    $ 19.06万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10419967
  • 财政年份:
    2022
  • 资助金额:
    $ 19.06万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10592441
  • 财政年份:
    2022
  • 资助金额:
    $ 19.06万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10369750
  • 财政年份:
    2021
  • 资助金额:
    $ 19.06万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10633248
  • 财政年份:
    2021
  • 资助金额:
    $ 19.06万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10487516
  • 财政年份:
    2021
  • 资助金额:
    $ 19.06万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    10228564
  • 财政年份:
    2018
  • 资助金额:
    $ 19.06万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    9347041
  • 财政年份:
    2017
  • 资助金额:
    $ 19.06万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9480702
  • 财政年份:
    2016
  • 资助金额:
    $ 19.06万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9906853
  • 财政年份:
    2016
  • 资助金额:
    $ 19.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了